Apeloa Pharmaceutical nears completion of share repurchase program

Apeloa Pharmaceutical Co., Ltd. announced on November 3, 2025, the progress of its share repurchase program. As of October 31, 2025, the company had cumulatively repurchased 10,060,000 shares through centralized bidding transactions. This represents 0.87% of the company's total share capital.

The repurchases were executed at a highest price of 15.03 yuan per share and a lowest price of 13.62 yuan per share, with the total transaction amount reaching 144,036,004 yuan, excluding transaction fees. The company's board initially approved the scheme on February 19, 2025, with a target repurchase value between 75,000,000 yuan and 150,000,000 yuan. The maximum repurchase price was adjusted from 22 yuan per share to 21.65 yuan per share effective May 22, 2025, and further to 21.30 yuan per share effective September 17, 2025, following dividend distribution and share bonus events.

The funding for the repurchase program was initially from "own funds" and was later expanded to include "own funds and borrowings from financial institutions" following board approval on April 25, 2025. Apeloa Pharmaceutical affirmed that the repurchase aligns with its approved plan and relevant laws and regulations, and it will continue to implement the program within the designated period.